Emercell

Developer of immunotherapies and cell therapies for the treatment of cancer

placeMontpellier, Occitanie, France calendar_todayFounded 2013 groups5 employees language emercell.com

Innovation

3 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 50 times.

YearFilings
20151
20161
20172
20181
20201
20211
20222
20251

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon